Urenco ChemPlants owns and will operate our most recent nuclear new build, Urenco’s Tails Management Facility.
Urenco ChemPlants Read moreSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report08 August 2018
Urenco read with interest yesterday’s report from the Expert Finance Working Group and will be reviewing the recommendations in detail.
In June, our micro-modular reactor technology – U-Battery – which we are developing with our consortium partners, successfully progressed to phase one of the Government’s Advanced Modular Reactor Programme.
During phase one of that programme we will produce a feasibility study which will make the commercial and technical case for U-Battery.
We are delighted at the Government’s show of support for advanced modular technologies and look forward to demonstrating how U-Battery can help to address energy and decarbonisation challenges in the UK and overseas.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries
Sign up to our newsletter by entering your email address below.